default author photo

Christopher Gast

PATH

SCHOLARLY PAPERS

2

DOWNLOADS

217

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Safety and Immunogenicity of a Nipah Virus Vaccine (Hev-Sg-V) in Adults: A Single-Centre, Randomised, Observer-Blind, Placebo-Controlled, Phase 1 Study

Number of pages: 31 Posted: 30 May 2024
Robert Frenck, Abdi Naficy, Jodi Feser, Michael Egan, Tracy Chen, Michelle Dickey, John H. Eldridge, Susan Sciotto-Brown, Luz Hermida, V. H. Leyva-Grado , Dominique H. Promeneur, Amara Luckay, Herbert Medina, Glorie-Grace H. Lazaro, Nairuti Patel, Tahira Naqvi, Christopher Gast, Laina D. Mercer, Mike Raine, Indah Andi-Lolo, Bruce L. Innis, John Aponte, Stefan Hamm and Niraj Rathi
Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, PATH, PATH, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Auro Vaccines LLC, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, PATH, PATH, PATH, PATH, PATH, PATH, PATH and PATH
Downloads 161 (464,454)
Citation 1

Abstract:

Loading...

Nipah virus, vaccine, randomised clinical trial, infectious diseases

2.

Efficacy and Safety of an Inactivated Whole-Virion Sars-Cov-2 Vaccine (Coronavac) in Brazilian Healthcare Professionals: The Profiscov Trial

Number of pages: 39 Posted: 06 Jun 2025
Jose Duarte Moreira, Elizabeth González Patiño, Patrícia E. Braga, Pedro H. M. Pacheco, Caroline Curimbaba, Christopher Gast, Ricardo Palacios, Mauro Martins Teixeira, Fabiano Ramos, Gustavo Adolfo Sierra Romero, Fabio Leal, Luiz Carlos Pereira Júnior, Luis Fernando Aranha Camargo, Francisco Hideo Aoki, Eduardo Barbosa Coelho, André Machado de Siqueira, Sonia Mara Raboni, Danise Senna Oliveira, Paulo Tarso, Cor Jesus Fernandes Fontes, Ana Lúcia Lyrio de Oliveira, Maurício Lacerda Nogueira and Esper Kallas
Oswaldo Cruz Foundation (FIOCRUZ) - Instituto Nacional de Infectologia Evandro Chagas (INIEC), Instituto Butantan, Instituto Butantan, Instituto Butantan, affiliation not provided to SSRN, PATH, Instituto Butantan, Federal University of Minas Gerais (UFMG), Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS) - School of Medicine, Universidade de Brasília (UnB), affiliation not provided to SSRN, Institute of Infectious Diseases Emilio Ribas, Hospital Israelita Albert Einstein, Universidade Estadual de Campinas (UNICAMP), University of São Paulo (USP) - Faculdade de Medicina de Ribeirão Preto, Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI), Federal University of Parana (UFPR), Federal University of Pelotas (UFPel), affiliation not provided to SSRN, Universidade Federal de Mato Grosso, Universidade Federal de Mato Grosso do Sul, Faculdade de Medicina de São José de Rio Preto (FAMERP) and Instituto Butantan
Downloads 56 (1,000,027)

Abstract:

Loading...

SARS-CoV-2, CoronaVac, Vaccine, Brazil, healthcare worker